Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % -61%
Quick Ratio 13.7 % -52.6%
Debt-to-equity 149 % -19.5%
Return On Equity -62.6 % +56.9%
Return On Assets -25.2 % +50.7%
Operating Margin -32.6 % +76.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 120M shares +2.58%
Common Stock, Shares, Outstanding 120M shares +2.85%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 127M shares +2.85%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +2.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 263M USD +99.5%
Research and Development Expense 71M USD -23.2%
Costs and Expenses 349M USD +12%
Operating Income (Loss) -85.8M USD +52.3%
Income Tax Expense (Benefit) 944K USD -72.5%
Net Income (Loss) Attributable to Parent -93.3M USD +53.1%
Earnings Per Share, Basic 0 USD/shares +63.4%
Earnings Per Share, Diluted 0 USD/shares +63.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.7M USD -13.7%
Accounts Receivable, after Allowance for Credit Loss, Current 107M USD +146%
Inventory, Net 16.3M USD +17.6%
Assets, Current 333M USD -23.4%
Property, Plant and Equipment, Net 1.39M USD +3.49%
Operating Lease, Right-of-Use Asset 1.73M USD -20.1%
Intangible Assets, Net (Excluding Goodwill) 15.9M USD +163%
Other Assets, Noncurrent 596K USD +0.17%
Assets 352M USD -20.8%
Accounts Payable, Current 15.1M USD +89.9%
Employee-related Liabilities, Current 12.3M USD +23.1%
Accrued Liabilities, Current 87.9M USD +106%
Liabilities, Current 104M USD +102%
Operating Lease, Liability, Noncurrent 2.11M USD -29%
Other Liabilities, Noncurrent 360K USD +85.6%
Liabilities 213M USD -17.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -35K USD +88.1%
Retained Earnings (Accumulated Deficit) -1.16B USD -8.72%
Stockholders' Equity Attributable to Parent 139M USD -25.5%
Liabilities and Equity 352M USD -20.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.4M USD +3.87%
Net Cash Provided by (Used in) Financing Activities 395K USD -99.8%
Net Cash Provided by (Used in) Investing Activities 11.8M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 120M shares +2.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.2M USD -118%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73M USD -13.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.57M USD -60.6%
Deferred Tax Assets, Valuation Allowance 256M USD +18.6%
Deferred Tax Assets, Gross 257M USD +18.5%
Operating Lease, Liability 3.38M USD -17.9%
Depreciation 153K USD -10%
Payments to Acquire Property, Plant, and Equipment 608K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -93M USD +53.2%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD -20.7%
Property, Plant and Equipment, Gross 3.61M USD +4.1%
Operating Lease, Liability, Current 842K USD +11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.05M USD +2.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD +3.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 436K USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD +3.13%
Deferred Tax Assets, Operating Loss Carryforwards 172M USD +12.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 42.3M USD +2.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 653K USD -39.9%
Additional Paid in Capital 1.3B USD +3.63%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.98M USD +1485%
Share-based Payment Arrangement, Expense 39.4M USD -4.52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%